Literature DB >> 26915455

Lysosomal cystine accumulation promotes mitochondrial depolarization and induction of redox-sensitive genes in human kidney proximal tubular cells.

Rodolfo Sumayao1, Bernadette McEvoy1, Philip Newsholme2, Tara McMorrow1.   

Abstract

KEY POINTS: Cystine is a disulphide amino acid that is normally generated in the lysosomes by the breakdown of cystine-containing proteins. Previously, we demonstrated that lysosomal cystine accumulation in kidney proximal tubular epithelial cells (PTECs) dramatically reduced glutathione (GSH) levels, which may result in the disruption of cellular redox balance. In the present study, we show that lysosomal cystine accumulation following CTNS gene silencing in kidney PTECs resulted in elevated intracellular reactive oxygen species production, reduced antioxidant capacity, induction of redox-sensitive proteins, altered mitochondrial integrity and augmented cell death. These alterations may represent different facets of a unique cascade leading to tubular dysfunction initiated by lysosomal cystine accumulation and may present a clear disadvantage for cystinotic PTECs in vivo. Cystine depletion by cysteamine afforded cytoprotection in CTNS knockdown cells by reducing oxidative stress, normalizing intracellular GSH and ATP content, and preserving cell viability. ABSTRACT: Cystine is a disulphide amino acid that is normally generated within the lysosomes through lysosomal-based protein degradation and via extracellular uptake of free cystine. In the autosomal recessive disorder, cystinosis, a defect in the CTNS gene results in excessive lysosomal accumulation of cystine, with early kidney failure a hallmark of the disease. Previously, we demonstrated that silencing of the CTNS gene in kidney proximal tubular epithelial cells (PTECs) resulted in an increase in intracellular cystine concentration coupled with a dramatic reduction in the total GSH content. Because of the crucial role of GSH in maintaining the redox status and viability of kidney PTECs, we assessed the effects of CTNS knockdown-induced lysosomal cystine accumulation on intracellular reactive oxygen species (ROS) production, activity of classical redox-sensitive genes, mitochondrial integrity and cell viability. Our results showed that lysosomal cystine accumulation increased ROS production and solicitation to oxidative stress (OS). This was associated with the induction of classical redox-sensitive proteins, NF-κB, NRF2, HSP32 and HSP70. Cystine-loaded PTECs also displayed depolarized mitochondria, reduced ATP content and augmented apoptosis. Treatment of CTNS knockdown PTECs with the cystine-depleting agent cysteamine resulted in the normalization of OS index, increased GSH and ATP content, and preservation of cell viability. Taken together, the alterations observed in cystinotic cells may represent different facets of a cascade leading to tubular dysfunction and, in combination with cysteamine therapy, may offer a novel link for the attenuation of renal injury and preservation of functions of other organs affected in cystinosis.
© 2016 The Authors. The Journal of Physiology © 2016 The Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26915455      PMCID: PMC4908017          DOI: 10.1113/JP271858

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  55 in total

1.  Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival.

Authors:  Sara B Cullinan; Donna Zhang; Mark Hannink; Edward Arvisais; Randal J Kaufman; J Alan Diehl
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

Review 2.  Redox regulation of NF-kappa B activation.

Authors:  L Flohé; R Brigelius-Flohé; C Saliou; M G Traber; L Packer
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

3.  Modulation of the intracellular cystine content of cystinotic fibroblasts by extracellular albumin.

Authors:  J G Thoene; R Lemons
Journal:  Pediatr Res       Date:  1980-06       Impact factor: 3.756

4.  Insights into novel cellular injury mechanisms by gene expression profiling in nephropathic cystinosis.

Authors:  Poonam Sansanwal; Li Li; Szu-Chuan Hsieh; Minnie M Sarwal
Journal:  J Inherit Metab Dis       Date:  2010-09-24       Impact factor: 4.982

5.  Cysteamine restores glutathione redox status in cultured cystinotic proximal tubular epithelial cells.

Authors:  Martijn J Wilmer; Leo A J Kluijtmans; Thea J van der Velden; Peter H Willems; Peter G Scheffer; Rosalinde Masereeuw; Leo A Monnens; Lambertus P van den Heuvel; Elena N Levtchenko
Journal:  Biochim Biophys Acta       Date:  2011-02-28

Review 6.  Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB.

Authors:  Y M Janssen-Heininger; M E Poynter; P A Baeuerle
Journal:  Free Radic Biol Med       Date:  2000-05-01       Impact factor: 7.376

7.  Effect of glutathione depletion on sites and topology of superoxide and hydrogen peroxide production in mitochondria.

Authors:  Derick Han; Raffaella Canali; Daniel Rettori; Neil Kaplowitz
Journal:  Mol Pharmacol       Date:  2003-11       Impact factor: 4.436

8.  Cystine dimethylester loading promotes oxidative stress and a reduction in ATP independent of lysosomal cystine accumulation in a human proximal tubular epithelial cell line.

Authors:  Rodolfo Sumayao; Bernadette McEvoy; Natalia Martin-Martin; Tara McMorrow; Philip Newsholme
Journal:  Exp Physiol       Date:  2013-06-28       Impact factor: 2.969

9.  Modulation of CTNS gene expression by intracellular thiols.

Authors:  Francesco Bellomo; Serena Corallini; Anna Pastore; Alessia Palma; Chiara Laurenzi; Francesco Emma; Anna Taranta
Journal:  Free Radic Biol Med       Date:  2010-01-14       Impact factor: 7.376

10.  Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.

Authors:  L Feliubadaló; M Font; J Purroy; F Rousaud; X Estivill; V Nunes; E Golomb; M Centola; I Aksentijevich; Y Kreiss; B Goldman; M Pras; D L Kastner; E Pras; P Gasparini; L Bisceglia; E Beccia; M Gallucci; L de Sanctis; A Ponzone; G F Rizzoni; L Zelante; M T Bassi; A L George; M Manzoni; A De Grandi; M Riboni; J K Endsley; A Ballabio; G Borsani; N Reig; E Fernández; R Estévez; M Pineda; D Torrents; M Camps; J Lloberas; A Zorzano; M Palacín
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

View more
  11 in total

1.  Cell-Based Phenotypic Drug Screening Identifies Luteolin as Candidate Therapeutic for Nephropathic Cystinosis.

Authors:  Ester De Leo; Mohamed A Elmonem; Sante Princiero Berlingerio; Marine Berquez; Beatrice Paola Festa; Roberto Raso; Francesco Bellomo; Tobias Starborg; Manoe Jacoba Janssen; Zeinab Abbaszadeh; Sara Cairoli; Bianca Maria Goffredo; Rosalinde Masereeuw; Olivier Devuyst; Martin Lowe; Elena Levtchenko; Alessandro Luciani; Francesco Emma; Laura Rita Rega
Journal:  J Am Soc Nephrol       Date:  2020-06-05       Impact factor: 10.121

2.  Impact of atypical mitochondrial cyclic-AMP level in nephropathic cystinosis.

Authors:  Francesco Bellomo; Anna Signorile; Grazia Tamma; Marianna Ranieri; Francesco Emma; Domenico De Rasmo
Journal:  Cell Mol Life Sci       Date:  2018-03-16       Impact factor: 9.261

3.  Cystinosis (ctns) zebrafish mutant shows pronephric glomerular and tubular dysfunction.

Authors:  Mohamed A Elmonem; Ramzi Khalil; Ladan Khodaparast; Laleh Khodaparast; Fanny O Arcolino; Joseph Morgan; Anna Pastore; Przemko Tylzanowski; Annelii Ny; Martin Lowe; Peter A de Witte; Hans J Baelde; Lambertus P van den Heuvel; Elena Levtchenko
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

Review 4.  The Role of Cystinosin in the Intermediary Thiol Metabolism and Redox Homeostasis in Kidney Proximal Tubular Cells.

Authors:  Rodolfo Sumayao; Philip Newsholme; Tara McMorrow
Journal:  Antioxidants (Basel)       Date:  2018-12-03

Review 5.  Effects of long-term cysteamine treatment in patients with cystinosis.

Authors:  Gema Ariceta; Vincenzo Giordano; Fernando Santos
Journal:  Pediatr Nephrol       Date:  2017-12-19       Impact factor: 3.714

Review 6.  In Vitro and In Vivo Models to Study Nephropathic Cystinosis.

Authors:  Pang Yuk Cheung; Patrick T Harrison; Alan J Davidson; Jennifer A Hollywood
Journal:  Cells       Date:  2021-12-21       Impact factor: 6.600

7.  Drug Repurposing in Rare Diseases: An Integrative Study of Drug Screening and Transcriptomic Analysis in Nephropathic Cystinosis.

Authors:  Francesco Bellomo; Ester De Leo; Anna Taranta; Laura Giaquinto; Gianna Di Giovamberardino; Sandro Montefusco; Laura Rita Rega; Anna Pastore; Diego Luis Medina; Diego Di Bernardo; Maria Antonietta De Matteis; Francesco Emma
Journal:  Int J Mol Sci       Date:  2021-11-27       Impact factor: 5.923

Review 8.  Programmed Cell Death in Cystinosis.

Authors:  Elizabeth G Ames; Jess G Thoene
Journal:  Cells       Date:  2022-02-15       Impact factor: 6.600

9.  CTNS mRNA molecular analysis revealed a novel mutation in a child with infantile nephropathic cystinosis: a case report.

Authors:  Svetlana Papizh; Victoria Serzhanova; Alexandra Filatova; Mikhail Skoblov; Vyacheslav Tabakov; Lambert van den Heuvel; Elena Levtchenko; Larisa Prikhodina
Journal:  BMC Nephrol       Date:  2019-10-31       Impact factor: 2.388

10.  Cultivation of Cells in a Physiological Plasmax Medium Increases Mitochondrial Respiratory Capacity and Reduces Replication Levels of RNA Viruses.

Authors:  Michail V Golikov; Inna L Karpenko; Anastasiya V Lipatova; Olga N Ivanova; Irina T Fedyakina; Viktor F Larichev; Natalia F Zakirova; Olga G Leonova; Vladimir I Popenko; Birke Bartosch; Sergey N Kochetkov; Olga A Smirnova; Alexander V Ivanov
Journal:  Antioxidants (Basel)       Date:  2021-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.